<DOC>
	<DOC>NCT00796289</DOC>
	<brief_summary>The primary objective of this study is to determine the safety and efficacy of pulsatile GnRH delivered from a iontophoretic patch (Lutrepatch) for induction of ovulation in women with anovulatory/ oligoovulatory infertility, compared to placebo and to a reference treatment with clomiphene citrate.</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1. Females between the ages of 18 and 38 years 2. Desire to become pregnant 3. Infertile due to ovulatory dysfunction as described below: Unable to conceive for at least 1 year and Anovulatory (defined as 4 or fewer menstrual cycles per year) or Oligoovulatory (defined as menstrual cycle frequency &gt; 45 days) 1. Requires donor oocytes or sperm 2. Two or more failed (defined as no biochemical pregnancy achieved) gonadotropin fertility treatment cycles if previous gonadotropin success, no more than two failed subsequent cycles 3. Use of insulinsensitizing drugs (e.g., Metformin) within 1 month prior to progesterone challenge</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>anovulatory/oligoovulatory infertility</keyword>
</DOC>